Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001523493 | SCV001733203 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001701719 | SCV001933269 | benign | Immunodeficiency 45 | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV003488329 | SCV004233667 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 29% of patients studied by a panel of primary immunodeficiencies. Number of patients: 28. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001523493 | SCV005307707 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000007711 | SCV000027912 | risk factor | Hepatitis B virus, susceptibility to | 2006-06-13 | no assertion criteria provided | literature only | |
HLA Laboratory, |
RCV002326668 | SCV002515915 | uncertain significance | Mortality risk in patients with severe coronavirus disease (COVID-19) | 2022-05-06 | no assertion criteria provided | research |